UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032290
Receipt number R000036818
Scientific Title Study of sentinel node mapping for uterine and cervical cancer
Date of disclosure of the study information 2018/04/17
Last modified on 2024/03/25 19:53:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of sentinel node mapping for uterine and cervical cancer

Acronym

Sentinel node mapping for uterine and cervical cancer

Scientific Title

Study of sentinel node mapping for uterine and cervical cancer

Scientific Title:Acronym

Sentinel node mapping for uterine and cervical cancer

Region

Japan


Condition

Condition

uterine and cervical cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the detection rate, safety and efficacy of sentinel lymph nodes using indocyanine green and near-infrared fluorescence imaging for uterine and cervical cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Histopathological diagnosis of dissected lymph nodes, positive rate of sentinel lymph node

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

sentinel node biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Female

Key inclusion criteria

Cervical Cancer: Stage IA1,IA2,IB1,IIA1 with tumor size less than 2cm
Uteine cancer: Stage IA,IB,II

Key exclusion criteria

Women with lymph node metastasis by image
Women has an allergy to iodine
Women has an allergy to indocyanine green
Women with advanced obesity

Target sample size

100


Research contact person

Name of lead principal investigator

1st name KAZU
Middle name
Last name Ueda

Organization

The Jikei university school of medicine

Division name

OBGYN

Zip code

105-8471

Address

3-19-18 Nishi-shinbashi Minato-ku, Tokyo, Japan

TEL

+81-3-3433-1111

Email

kazu@jikei.ac.jp


Public contact

Name of contact person

1st name KAZU
Middle name
Last name Ueda

Organization

The Jikei university school of medicine

Division name

OBGYN

Zip code

105-8471

Address

3-19-18 Nishi-shinbashi Minato-ku, Tokyo, Japan

TEL

+81-3-3433-1111

Homepage URL


Email

kazu@jikei.ac.jp


Sponsor or person

Institute

The Jikei university school of medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei university school of medicine

Address

3-19-18 Nishi-shinbashi Minato-ku, Tokyo

Tel

0334331111

Email

kazu@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 03 Month 03 Day

Date of IRB

2017 Year 12 Month 04 Day

Anticipated trial start date

2018 Year 03 Month 05 Day

Last follow-up date

2025 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 17 Day

Last modified on

2024 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036818


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name